Navigation Links
Protein Discovery Could Unlock The Secret To Better TB Treatment

UCL scientists have found a protein that could unlock the secret to quicker, more effective treatment of TB by waking TB bacteria in the body. Once the TB bacteria are active again, the disease becomes treatable using common drugs like antibiotics. Scientists believe that uncovering the molecular structure of this protein will lead the way to designing drugs which enable treatment of dormant and multidrug resistant TB.

In England and Wales around 400 people die each year from the disease. The top challenge for TB control in the European region is multidrug-resistant TB (MDR-TB). Eight per cent of the bacteria causing TB in patients are resistant to one or more drugs and one per cent show multidrug resistance. Left untreated, a person with infectious TB of the lungs infects around 10 to 15 people every year.

In a study published on 1st March 2005 in Nature Structural & Molecular Biology, a combined team discovered the structure of a protein known as resuscitation promoting factor (Rpf). Five versions of the Rpf protein exist in TB bacteria. The paper's unveiling of the molecular structure of Rpf could be crucial to the treatment of TB in the future.

Dr John Ward, Dept of Biochemistry and Molecular Biology at UCL, said: "The discovery of Rpf in the TB bacteria could allow the development of methods to 'wake-up' all dormant bacteria in a patient allowing antibiotics to kill the bacteria and cure the disease."

The team includes Prof Brian Henderson at the UCL Eastman Dental Institute, Nicholas Keep from Birkbeck, University of London, and John Ward at UCL as well as researchers from INSERM Montpellier.


'"/>

Source:University College London


Page: 1

Related biology news :

1. Quantum Dots Research Leads to New Knowledge about Protein Binding in Plants
2. Protein discovery could unlock the secret to better TB treatment
3. Researchers Uncover Key Step In Manufacture of Memory Protein
4. An HIV Protein Plays a Surprising Role in Gene Activation
5. Protein Packages Found To Activate Genes; May Be What Regulates Development And Disease
6. New SARS Protein Linked To Important Cell Doorway
7. The Shapes Of Life: NIGMS Project Yields More Than 1,000 Protein Structures
8. PANTHER Protein Classification System Database 5.0
9. Duke Chemists Isolating Individual Molecules Of Toxic Protein In Alzheimers, Parkinsons Disease
10. Newly Discovered Compound Blocks Known Cancer-Causing Protein
11. UF Researchers Map Bacterial Proteins That Cause Tooth Loss

Post Your Comments:
(Date:11/4/2009)...tural science) , United States Using Less Wate...ay than it did 35 years ago, despite a 30 percent ...tly attributable to alternative cooling methods at...s. According to the latest USGS water use report, ... goes to cooling thermoelectric power plants. Irri...
(Date:11/4/2009)...teria, it turns out, hold the power to help milita... world clean up toxic waste on test sites. , Com... invented back in World War II and have been used ...rgy compounds are often used to propel tank shells... But with increased knowledge of their environmen...
(Date:11/4/2009)...., Oct. 19 Spectros, developer and...aging devices which shed light on life-threatening...usive distribution deals for both its T-Stat®...ered include Australia, New Zealand, The Netherla...y, France, Spain, Portugal, Poland, Greece, Turkey...
Breaking Biology News(10 mins):USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Genomic research will enable greener cleanup of military explosive test sites 2Spectros Signs New International Distribution Deals 2VIVUS Announces Promotion of Peter Tam to President 5941 1VIVUS Announces Promotion of Peter Tam to President 5941 2VIVUS Announces Promotion of Peter Tam to President 5941 3MarketsandMarkets 3A Global Stem Cell and Advanced Technologies Market Worth US 24 88 3 Billion By 2014 14699 1MarketsandMarkets 3A Global Stem Cell and Advanced Technologies Market Worth US 24 88 3 Billion By 2014 14699 2MarketsandMarkets 3A Global Stem Cell and Advanced Technologies Market Worth US 24 88 3 Billion By 2014 14699 3Hearing Planet Publishes Hearing Aid Buyers 26apos 3B Guide 60589 1Hearing Planet Publishes Hearing Aid Buyers 26apos 3B Guide 60589 2
...the University of Michigan Medical School have dis...arly-onset form of kidney disease and renal failur...d phospholipase C epsilon or PLCE1. , Identifying ... PLCE1 affects the development of podocytes ?speci...s ability to remove waste products from blood, whi...
... the Université de Montréal has concluded that peo...r a night of studying will strongly hurt their rec...he current issue of Neuropsychopharmacology was co...f Psychology at the Université de Montréal. Dr. Ca...ital du Sacré-Coeur de Montréal. , "We already kn...
...al studies of the interactions between oscillating...the toughest questions in ecology, including the n...ing to an article in the December 2006 issue of Bi...niversity of Michigan, shows how extensions of est... populations oscillate in synchrony because of int...
Other Biology News:Mutant gene causes severe kidney disease in infants 2Mutant gene causes severe kidney disease in infants 3Mutant gene causes severe kidney disease in infants 4Negative effects of caffeine are stronger on daytime sleep than on nocturnal sleep 2
(Date:11/9/2009)..., SAN DIEGO, Nov. 9 NexBio, Inc....9 annual American College of Allergy, Asthma, and ...s entitled "DAS181 (Fludase®), a Sialidase, D...lammatory Effects in Animal Models of Asthma". ,...broad spectrum host-targeting drug candidate being...
(Date:11/9/2009)... Product release is a resea...ubjects, research facilities and research safety s...n. , Cedar Knolls, NJ (PR...nounced today that it has unveiled Pristima™...r research facilities that track the use and care ...
(Date:11/8/2009)...,, MOUNTAIN VIEW, Calif. Nov. 5, 2009 Comple...ncing company, today announced publication of a re...ietary DNA sequencing platform, including analysis...s. The consumables cost for these three genomes se...arrays ranged from $8,005 for 87x coverage to $1,7...
(Date:11/6/2009)..., LYNBROOK, N.Y., Nov. 6 /PRNewswire-FirstCall/ ...), a biopharmaceutical company developing first-in... its financial results for the third quarter ended...py that, in September of this year, the FDA,s Arth...by a vote of 12-0, the approval of XIAFLEX(TM) for...
Breaking Biology Technology:NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 2NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 3Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6
...auna Kea Technologies and VisualSonics today annou...ion agreement through which VisualSonics will mark...imaging systems to pre-clinical researchers on a w...rs with a new way to understand physiological phen...itu in animal subjects. For the first time, pre-cl...
...Nasdaq: IDMI ) today reported financial results ...r 31, 2008. Financial information presented repre... and its subsidiary, IDM Pharma S.A. , , Total re... $0.3 million, and net loss was $1.8 million or $0... the year ended December 31, 2008 were $3.1 millio...
...SHP,NASDAQ: SHPGY ), the global specialty biopha...n agreement with GlaxoSmithKline plc (NYSE: GSK ...sules CII with the aim of,improving recognition an...eement covers the United States and will more than...es effort for VYVANSE by adding over 600 sales,rep...
Other Biology Technology:VisualSonics to Sell Mauna Kea Technologies' Cellvizio(R) LAB on a Worldwide Basis to Animal Imaging Market 2VisualSonics to Sell Mauna Kea Technologies' Cellvizio(R) LAB on a Worldwide Basis to Animal Imaging Market 3IDM Pharma Reports 2008 Financial Results 2IDM Pharma Reports 2008 Financial Results 3IDM Pharma Reports 2008 Financial Results 4IDM Pharma Reports 2008 Financial Results 5IDM Pharma Reports 2008 Financial Results 6IDM Pharma Reports 2008 Financial Results 7IDM Pharma Reports 2008 Financial Results 8Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD 2Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD 3Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD 4Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD 5Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD 6
Peptone from Sigma-Aldrich
...2 cells were cultured in Minimum Essential Medium ... log phase of growth. In order to keep the antige...one-methanol. The cells are arrayed on a 12-well ...ace specifically treated to enhance cellular attac...
...ells were cultured in Minimum Essential Medium (Ea...g phase of growth. In order to keep the antigens ...-methanol. The cells are arrayed on a 12-well (5 ... specifically treated to enhance cellular attachme...
...Plus Microsphere/Microarray Stabilizer is an aqueo...n and other non-toxic chemicals in a PBS buffer (p...uct contains a combination of 0.02% methylisothiaz...e. StabilCoat Plus Stabilizer provides optimum pe...
Biology Products: